Literature DB >> 4217572

Experimental louse-borne relapsing fever in the grivet monkey, Cercopithecus aethiops. III. Crisis following therapy.

D M Judge, J T La Croix, P L Perine.   

Abstract

Eight grivet monkeys infected with Borrelia recurrentis received tetracycline (12.5mg/kg body weight) on the 3rd or 4th day of spirochetemia. Leukopenia, fever, hyperpnea, and tachycardia developed within 2 hours as spirochete counts fell to undetectable levels. These events closely simulated the crisis in human louse-borne relapsing fever in both timing and extent.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4217572     DOI: 10.4269/ajtmh.1974.23.969

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  2 in total

1.  The First Immunocompetent Mouse Model of Strictly Human Pathogen, Borrelia recurrentis.

Authors:  Artem S Rogovskyy; Yuliya V Rogovska; Brianne M Taylor; Dominique J Wiener; David W Threadgill
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

Review 2.  Pathogenesis of Relapsing Fever.

Authors:  Job Lopez; Joppe W Hovius; Sven Bergström
Journal:  Curr Issues Mol Biol       Date:  2020-12-29       Impact factor: 2.081

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.